Trial Profile
A retrospective trial of abiraterone assessing abiraterone withdrawal syndrome (AWS) in patients with metastatic castration-resistant prostate cancer (mCRPC)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 31 Mar 2016
Price :
$35
*
At a glance
- Drugs Abiraterone acetate (Primary) ; Prednisone
- Indications Prostate cancer
- Focus Therapeutic Use
- 31 Mar 2016 New trial record